ArticleRheumatology (Oxford, England)2023
Comment on: Efficacy and safety of tocilizumab in Behçet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China: reply.
Hua Zhong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.